On Friday, the British medical devices company Smith & Nephew Plc., reported a 73% rise in third-quarter net profit and shared the anticipation that the market for replacement hips and knees is stabilizing.

Becton Dickinson & Co recorded a decent increase in profit for the fourth quarter at 12 per cent. The revenue for the quarter also rose by 5 per cent all due to the high sales in the diagnostic and medical unit of the company.

In a letter to physicians, Medtronic Inc. has warned that nearly 37,000 of its pacemakers, produced late 1990s onwards, could possibly have wiring defects due to which a malfunctioning of the medical equipment is quite possible.

In its endeavor to expand its growing diabetes business, the Minneapolis-based medical device maker Medtronic Inc. intends making 1,400 job-additions in the coming five-year period, at its new San Antonio, Texas-based customer support facility, scheduled to open late this summer.

The recent study has shown that a device placed in the heart is more effective in reducing risk of stroke due to a common heart-rhythm disorder as compared to anti-clotting drug.

U. S. Democrats on Thursday moved a legislation to overturn a 2008 ruling that protected medical device companies from being sued by patients over harm from their products that were approved by the Food and Drug Administration.

Baxa Corporation, a customer-focused medical device company, has informed that it has acquired ForHealth Technologies, Inc., a Florida-based healthcare robotics and software company, in a strategic expansion of its focus on health-system pharmacy automation and IV room productivity.

Minneapolis-headquartered Medtronic, Inc. has signed a definitive agreement to acquire CoreValve, Inc., developer of a transcatheter, transfemoral aortic valve replacement product.

Medtronic Inc’s implantable deep brain stimulator, Reclaim DBS Therapy, has received the FDA approval for facilitating the treatment process in severe cases of obsessive-compulsive disorder (OCD), in which drug and psychotherapy have been futile.

The Bedford, Massachusetts-based Hologic Inc., a medical diagnostics company, reported a better-than-expected first quarter profit and a 16 percent increase in revenue. Nonetheless, based on the drop in hospital capital equipment spending, especially for its mammography product line, the company posted a weak outlook for the second quarter.